MY102123A - Antidepressant 1,2,4- trazolone compounds - Google Patents

Antidepressant 1,2,4- trazolone compounds

Info

Publication number
MY102123A
MY102123A MYPI87002743A MYPI19872743A MY102123A MY 102123 A MY102123 A MY 102123A MY PI87002743 A MYPI87002743 A MY PI87002743A MY PI19872743 A MYPI19872743 A MY PI19872743A MY 102123 A MY102123 A MY 102123A
Authority
MY
Malaysia
Prior art keywords
compounds
trazolone
antidepressant
phenoxyyalkyl
halophenyl
Prior art date
Application number
MYPI87002743A
Other languages
English (en)
Inventor
E Gammans Richard
W Smith David
P Yevich Joseph
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24145128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY102123(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of MY102123A publication Critical patent/MY102123A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MYPI87002743A 1983-09-30 1987-10-01 Antidepressant 1,2,4- trazolone compounds MY102123A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/538,027 US4613600A (en) 1983-09-30 1983-09-30 Antidepressant 1,2,4-triazolone compounds
GB08424535A GB2147297B (en) 1983-09-30 1984-09-28 Antidepressant 1,2,4-triazolone compounds

Publications (1)

Publication Number Publication Date
MY102123A true MY102123A (en) 1992-03-31

Family

ID=24145128

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87002743A MY102123A (en) 1983-09-30 1987-10-01 Antidepressant 1,2,4- trazolone compounds

Country Status (25)

Country Link
US (1) US4613600A (en:Method)
JP (1) JPS60100560A (en:Method)
KR (1) KR880002624B1 (en:Method)
AT (1) AT387963B (en:Method)
AU (1) AU561460B2 (en:Method)
BE (1) BE900714A (en:Method)
CA (1) CA1237723A (en:Method)
CH (1) CH661924A5 (en:Method)
CY (1) CY1541A (en:Method)
DE (1) DE3435745C2 (en:Method)
DK (1) DK169546B1 (en:Method)
ES (1) ES8601966A1 (en:Method)
FI (1) FI83310C (en:Method)
FR (1) FR2552759B1 (en:Method)
GB (1) GB2147297B (en:Method)
GR (1) GR80475B (en:Method)
HK (1) HK37391A (en:Method)
IE (1) IE58084B1 (en:Method)
IT (1) IT1178522B (en:Method)
LU (1) LU85561A1 (en:Method)
MY (1) MY102123A (en:Method)
NL (1) NL8402946A (en:Method)
SE (1) SE465928B (en:Method)
YU (1) YU45667B (en:Method)
ZA (1) ZA847589B (en:Method)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
US5504086A (en) * 1989-10-17 1996-04-02 Ellinwood, Jr.; Everett H. Intraoral dosing method of administering trifluorobenzodiazepines, propoxyphene, and nefazodone
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
DE4425144A1 (de) * 1994-07-15 1996-01-18 Basf Ag Triazolverbindungen und deren Verwendung
US6403593B1 (en) 1995-07-14 2002-06-11 Abbott Laboratories Triazole compounds and the use thereof
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung
JP2002541192A (ja) * 1999-04-09 2002-12-03 セプラコール, インク. S−ヒドロキシネファゾドン
AU4215300A (en) * 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20050233010A1 (en) * 2004-04-19 2005-10-20 Satow Philip M Lithium combinations, and uses related thereto
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2009111031A2 (en) * 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
CN104208718B (zh) 2009-02-20 2017-12-29 2-Bbb医疗股份有限公司 基于谷胱甘肽的药物递送系统
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
WO2013036830A1 (en) * 2011-09-09 2013-03-14 The Board Of Trustees Of The Leland Standford Junior University Topical itraconazole formulations and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
SE8404869L (sv) 1985-03-31
SE465928B (sv) 1991-11-18
DE3435745A1 (de) 1985-04-11
YU45667B (sh) 1992-07-20
IT8422922A0 (it) 1984-09-28
YU172184A (en) 1986-10-31
FR2552759B1 (fr) 1988-10-07
KR850002270A (ko) 1985-05-10
JPS60100560A (ja) 1985-06-04
FI83310C (fi) 1991-06-25
GR80475B (en) 1985-01-31
IT1178522B (it) 1987-09-09
BE900714A (fr) 1985-03-28
DE3435745C2 (de) 1994-11-03
ES536286A0 (es) 1985-11-16
SE8404869D0 (sv) 1984-09-28
HK37391A (en) 1991-05-24
AT387963B (de) 1989-04-10
GB2147297B (en) 1987-04-15
JPH0542435B2 (en:Method) 1993-06-28
GB2147297A (en) 1985-05-09
DK468284D0 (da) 1984-09-28
KR880002624B1 (ko) 1988-12-07
ES8601966A1 (es) 1985-11-16
NL8402946A (nl) 1985-04-16
CA1237723A (en) 1988-06-07
FR2552759A1 (fr) 1985-04-05
IE842476L (en) 1985-03-30
CH661924A5 (de) 1987-08-31
AU3364884A (en) 1985-04-04
IE58084B1 (en) 1993-06-30
AU561460B2 (en) 1987-05-07
FI843779L (fi) 1985-03-31
FI843779A0 (fi) 1984-09-26
ATA310884A (de) 1988-09-15
CY1541A (en) 1991-03-22
DK169546B1 (da) 1994-11-28
ZA847589B (en) 1985-05-29
LU85561A1 (fr) 1985-06-04
GB8424535D0 (en) 1984-11-07
FI83310B (fi) 1991-03-15
DK468284A (da) 1985-03-31
US4613600A (en) 1986-09-23

Similar Documents

Publication Publication Date Title
MY102123A (en) Antidepressant 1,2,4- trazolone compounds
DK89595A (da) Fremgangsmåde til fremstilling af 1-(3-dimethylaminopropyl)-1'-(4-fluorphenyl)-1,3-dihydroisobenzofuran-5-carbonnitril
TR200001603T2 (tr) Yeni bileşikler
BG101198A (en) Use of 2-[(dihydro)pyrazolyl-3'-oxymethylene]-anilides as pest-control agents and fungicides
DE60113514D1 (de) 2-oxo-1-pyrrolidinderivate, verfahren zu ihrer herstellung und ihre verwendung
TR200000014T2 (tr) Yeni ikameli imidazol bileşimleri.
NO2001021I1 (no) Levosimendan
NO20000521D0 (no) 1-(N-fenylaminoalkyl)-piperazin derivater substituert i posisjon 2 på fenylringen
MX9602493A (es) Aril y heteroaril pirimidinas herbicidas.
BG106930A (en) Substituted phenyl-piperazine derivatives, their preparation and use
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
ATE423555T1 (de) Verwendung von beta-3-adrenergen-rezeptoren agonisten in der behandlung von dysurie
ATE178886T1 (de) 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
ATE237585T1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
KR930703259A (ko) 살균성 이소퀴놀린 유도체
TR200202195T2 (tr) 5-Yer değiştirmiş 1-(4-florofenil)-1,3- dihidroizobenzofuran'ın adım adım alkillenmesi
AR227542A1 (es) Procedimiento para preparar derivados de 4-(4-amino-6,7-dimetoxi-quinazolin-2-il)-1-(2,4-dioxo-2,2,3,4-tetrahidro-pirimidin-6-il)-piperazina
KR960016716A (ko) 테트라졸리논
TR199700547A2 (xx) N-asetonilbenzamid fungisitler.
ES2001809A6 (es) Un procedimiento para la preparacion de nuevas 3-(4,-fenil-piperazinil)alquil-quinazolin-2,4-(1h,3h)-dionas sustituidas
ATE394105T1 (de) Substituierte 4,5-dihydro-1,2,4-triazin-3-one, 1, 2,4-triazin-3-one sowie deren verwendung als fungizide und insektizide
ATE207481T1 (de) Kristallformen von 1-(5-methansulfonamidoindolyl- 2-carbonyl)-4-(3-(1-methylethylamino)-2- pyridinyl) piperazin
EP0885610A4 (en) Tracheal smooth muscle relaxant
EP0174584A3 (de) Salicylamid-Derivate
DE59806444D1 (de) Phenylketiminooxybenzylverbindungen, verfahren zu ihrer herstellung und ihre verwendung